Orthofix International | OFIX - Current Assets


Orthofix International reported $461.52M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
EDAP TMS EUR 44.35M 7.13M Sep/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.17B 12.47M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Plus Therapeutics USD 15.17M 2.42M Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Stryker USD 13.34B 1.42B Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Veracyte USD 488.38M 39.15M Dec/2025
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026